Hemogenyx Pharmaceuticals Plc (HOPHF)
Hemogenyx Pharmaceuticals Plc is a preclinical-stage biotechnology firm dedicated to discovering, developing, and bringing to market innovative therapies for various blood-related diseases. The company's pipeline includes several promising candidates tailored for the bone marrow/hematopoietic stem cell (BM/HSC) transplant market. These include a CDX bi-specific antibody designed to target relapsed/refractory acute myeloid leukemia (R/R AML), certain forms of acute lymphoblastic leukemia, and myelodysplastic syndrome. This novel approach seeks to condition patients for bone marrow transplants, offering a potential alternative to conventional chemotherapy and/or radiation treatments. Additionally, Hemogenyx is advancing HEMO-CAR-T therapy, which utilizes chimeric antigen receptor T-cells to specifically identify and eradicate human AML-derived cells, demonstrated in both in vitro and in vivo studies. Its portfolio also features Human Postnatal Hematopoietic Endothelial Cells, a unique stem cell therapy intended for BM/HSC transplant applications. Established in 2012, the company maintains its headquarters in London, United Kingdom.
Sector: Biotechnology
Industry: Biotechnology
Hemogenyx Pharmaceuticals Plc
Past the 1:250 Nasdaq cap, ineligible for a bid-price compliance period
- 1:400Reverse splitDec 13, 2024400 shares → 1
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2015-02-28 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $9K | $0 |
| YoY Growth | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | $1.23M | $1.06M | $2.23M | $3.43M | $374K | $463K | $557K | $460K | $133K | $88K | $0 | $0 |
| Gross Profit | -$1.23M | -$1.06M | -$2.23M | -$3.43M | -$374K | -$463K | -$557K | -$460K | -$133K | -$88K | $9K | $0 |
| Gross Margin | - | - | - | - | - | - | - | - | - | - | 100.0% | - |
| Research and Development | $0 | $312K | $120 | $643 | $67 | $151 | $37 | $97 | $25 | $0 | $0 | $0 |
| Selling, General, and Administrative | $2.24M | $6.25M | $6K | $6.46M | $1.84M | $2.8M | $611K | $2.15M | $541K | $544K | $233K | $8K |
| Other | $5.74M | $1.84M | $2K | -$643 | $1.72M | -$150 | $1.04M | -$398K | $545K | -$26K | $0 | $0 |
| Total Operating Expenses | $7.99M | $8.4M | $9K | $6.46M | $3.57M | $2.8M | $1.65M | $1.75M | $1.09M | $518K | $233K | $8K |
| Operating Income (EBIT) | -$9.21M | -$7.1M | -$9K | $5.28M | -$3.57M | -$2.84M | -$2.22M | -$2.22M | -$1.15M | -$606K | -$224K | -$8K |
| Operating Margin | - | - | - | - | - | - | - | - | - | - | -2481.5% | - |
| Interest Expense | $303K | $448K | $304 | $44 | $3.43M | $44K | $41K | $2K | $14K | $16K | $0 | $0 |
| Interest Income | $1K | $38K | $0 | $14K | $24K | $4K | $19K | $6K | $19 | $19 | $21 | $0 |
| Other Income (Expense) | -$3.68M | -$328K | -$304 | $14K | -$3.17M | $73K | $259K | $124K | -$2.03M | -$16K | -$15K | $0 |
| Income Before Tax (EBT) | -$12.89M | -$7.42M | -$9K | -$5.26M | -$6.74M | -$2.77M | -$1.96M | -$2.1M | -$3.18M | -$621K | -$239K | -$8K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | -$46K | -$58K | -$66K | $0 | -$21 | $0 |
| Net Income | -$12.88M | -$7.42M | -$9K | -$5.25M | -$6.73M | -$2.75M | -$1.91M | -$2.04M | -$3.12M | -$1.33M | -$239K | -$8K |
| Net Income Margin | - | - | - | - | - | - | - | - | - | - | -2642.4% | - |
| Supplementary Data | ||||||||||||
| EPS | -2.20 | -2.13 | -2.37 | -1.62 | -2.64 | -2.01 | -1.61 | -1.72 | -3.63 | -1.30 | -0.01 | -0.00 |
| Diluted EPS | -2.20 | -2.13 | -2.37 | -1.62 | -2.64 | -2.01 | -1.61 | -1.72 | -3.63 | -1.30 | -0.01 | -0.00 |
| Weighted Average OS | 4.44M | 3.30M | 2,822 | 2,449 | 1,934 | 1,037 | 901 | 900 | 650 | 362 | 632,868 | 64.90M |
| EBITDA | -$11.81M | -$6.25M | $845K | -$6.45M | -$3.4M | -$2.7M | -$2.1M | -$2.15M | -$1.1M | -$590K | $0 | -$8K |
| EBITDA Margin | - | - | - | - | - | - | - | - | - | - | - | - |
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2015-02-28 |
| Assets | ||||||||||||
| Current Assets | ||||||||||||
| Cash and Cash Equivalents | $2.09M | $210K | $1.65M | $3.34M | $9.03M | $2.39M | $658K | $2.33M | $2.48M | $1.38M | $63K | $8K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $2.09M | $210K | $1.65M | $3.34M | $9.03M | $2.39M | $658K | $2.33M | $2.48M | $115K | $63K | $8K |
| Accounts Receivable | $12K | $5K | $1K | $193 | $2K | $7K | $40K | $85K | $87K | $217K | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$427K | $0 | $0 |
| Other Current Assets | $5K | $5K | $4K | $13K | $8K | $67K | $3K | -$393 | -$2K | $424K | $0 | $49K |
| Total Current Assets | $2.69M | $1.11M | $2.86M | $3.42M | $9.42M | $2.53M | $732K | $2.45M | $2.57M | $329K | $117K | $58K |
| Long-Term Assets | ||||||||||||
| Property, Plant & Equipment Net | $2.38M | $3.6M | $4.37M | $5.17M | $1.05M | $355K | $308K | $230K | $253K | $232K | $0 | $0 |
| Goodwill | $0 | $0 | $38K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $240K | $630K | $583K | $583K | $583K | $336K | $346K | $360K | $340K | $372K | $311K | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $207K | $222K | $203K | $186K | $188K | $295K | $0 | $0 | $0 | -$995 | $0 | $0 |
| Total Long-Term Assets | $2.83M | $4.45M | $5.2M | $5.94M | $1.82M | $986K | $654K | $590K | $593K | $602K | $311K | $0 |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $5.51M | $5.56M | $8.06M | $9.36M | $11.25M | $3.52M | $1.39M | $3.04M | $3.16M | $1.38M | $428K | $58K |
| Liabilities | ||||||||||||
| Current Liabilities | ||||||||||||
| Accounts Payable | $1.27M | $902K | $398K | $494K | $390K | $149K | $81K | $121K | $10K | $22K | $7K | $0 |
| Short-Term Debt | $584K | $559K | $0 | $0 | $0 | $2.08M | $0 | $0 | $0 | $51K | $15K | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | -$502K | -$491K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Current Liabilities | $1.94M | $1.53M | $861K | $988K | $466K | $2.35M | $240K | $221K | $348K | $73K | $21K | $0 |
| Long-Term Liabilities | ||||||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $1.51M | $1.55M | $0 | $348K | $304K | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Liabilities | $2.06M | $2.9M | $3.53M | $4.09M | $0 | $13K | $1.61M | $1.55M | $0 | $348K | $304K | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$348K | $0 | $0 |
| Total Liabilities | $4M | $4.43M | $4.39M | $5.08M | $466K | $2.36M | $1.85M | $1.77M | $348K | $190K | $326K | $0 |
| Stockholders' Equity | ||||||||||||
| Preferred Stock | $0 | $0 | $0 | $78K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $18.53M | $46K | $15.52M | $12.93M | $12.93M | $5.72M | $4.77M | $4.75M | $4.75M | $883K | $341K | $66K |
| Retained Earnings | -$59.26M | -$38.83M | -$31.42M | -$22.59M | -$17.34M | -$10.61M | -$7.86M | -$6M | -$3.97M | -$801K | -$239K | -$8K |
| Comprehensive Income & Other | $3.72M | $11.74M | -$6.69M | -$78K | -$6.97M | -$7.13M | -$7.53M | -$7.17M | -$7.66M | $30K | $0 | $0 |
| Other Stockholders' Equity | $42.31M | $39.97M | $19.62M | $13.98M | $15.22M | $6.06M | $2.63M | $2.52M | $2.03M | $1.11M | -$1 | $0 |
| Total Equity | $1.58M | $1.18M | $3.72M | $4.32M | $10.81M | $1.18M | -$457K | $1.27M | $2.81M | $1.19M | $103K | $58K |
| Minority Interest | -$67K | -$58K | -$50K | -$42K | -$32K | -$20K | -$3K | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $5.58M | $5.62M | $8.11M | $9.4M | $11.28M | $3.54M | $1.39M | $3.04M | $3.16M | $1.38M | $428K | $58K |
| Supplementary Data | ||||||||||||
| Total Debt | $2.65M | $3.46M | $3.89M | $4.52M | $13K | $2.15M | $1.66M | $1.55M | $0 | $397K | $319K | $0 |
| Net Debt | $551K | $3.25M | $2.24M | $1.17M | -$9.02M | -$243K | $1M | -$778K | -$2.48M | -$983K | $256K | -$8K |
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2015-02-28 |
| Operating Activities | ||||||||||||
| Net Income | -$12.89M | -$7.42M | -$8.84M | -$5.26M | -$6.74M | -$2.77M | -$1.92M | -$2.04M | -$3.12M | -$621K | -$239K | -$8K |
| Depreciation & Amortization | $777K | $844K | $852K | $742K | $167K | $141K | $125K | $68K | $44K | $16K | $224K | $0 |
| Deferred Income Tax | $0 | $0 | $0 | $5K | -$24K | -$194K | $27K | -$65K | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $83K | $454K | $321K | $23K | $202K | $479K | $162K | $408K | $47K | $106K | $73K | $0 |
| Changes in Working Capital: | ||||||||||||
| Accounts Receivable | -$7K | -$3K | $6K | -$3K | -$260K | -$28K | $21K | -$25K | $114K | -$215K | -$55K | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $0 | $0 | $0 | -$36K | $393K | -$47K | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Working Capital | $1.27M | $342K | -$1.11M | $359K | $393K | $822 | -$24K | -$130K | -$2K | $0 | $0 | $0 |
| Total Working Capital Change | $1.26M | $338K | -$1.1M | $320K | $134K | -$75K | -$2K | -$156K | $112K | -$215K | -$55K | $0 |
| Other Non-Cash Items | $6.22M | $325K | $707K | $330K | $2.8M | $40K | $23K | -$3K | $2.32M | $2K | $102K | $0 |
| Net Cash from Operating | -$4.55M | -$5.46M | -$8.06M | -$3.84M | -$3.47M | -$2.37M | -$1.58M | -$1.79M | -$598K | -$713K | $105K | -$8K |
| Investing Activities | ||||||||||||
| Capital Expenditures | -$5K | -$18K | -$155K | -$566K | -$1.08M | -$228K | -$16K | -$32K | -$85K | -$249K | $0 | $0 |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.45M | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | -$3K | -$183K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | -$4K | $15K | $113K | $14K | $24K | $4K | $19K | $6K | -$368 | $288 | -$311K | $0 |
| Net Cash from Investing | -$9K | -$2K | -$42K | -$555K | -$1.24M | -$224K | $3K | -$27K | $1.36M | -$249K | -$311K | $0 |
| Financing Activities | ||||||||||||
| Debt Repaid | - | $838K | - | - | -$11.64M | -$4.76M | - | -$1.55M | $204K | - | - | - |
| Common Stock Issuance | $7.29M | $6.13M | $6.72M | $0 | $15.84M | $46K | $0 | $7K | $2.64M | $996K | $0 | $16K |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$835K | -$1.23M | -$843K | -$145K | -$76K | -$572K | -$52K | $0 | -$830K | $0 | $268K | $0 |
| Net Cash from Financing | $6.45M | $4.06M | $5.87M | -$145K | $11.59M | $4.24M | -$52K | $1.56M | $1.61M | $996K | $268K | $16K |
| Forex Effect | -$10K | -$32K | $532K | -$1.16M | -$241K | $92K | -$35K | $103K | -$11K | $18K | $0 | $0 |
| Net Change in Cash | $1.88M | -$1.44M | -$1.7M | -$5.69M | $6.64M | $1.73M | -$1.67M | -$151K | $2.36M | $53K | $63K | $8K |
| Supplementary Data | ||||||||||||
| Operating Cash Flow | -$4.55M | -$5.46M | -$8.06M | -$3.84M | -$3.47M | -$2.37M | -$1.58M | -$1.79M | -$598K | -$367K | $105K | -$8K |
| Capital Expenditure | -$5K | -$18K | -$155K | -$566K | -$1.08M | -$228K | -$16K | -$32K | -$85K | -$249K | $0 | $0 |
| Free Cash Flow | -$4.56M | -$5.48M | -$8.21M | -$4.41M | -$4.55M | -$2.6M | -$1.6M | -$1.82M | -$683K | -$616K | $105K | -$8K |
| Cash at Beginning | $210K | $1.65M | $3.34M | $9.03M | $2.39M | $658K | $2.33M | $2.48M | $115K | $1.75M | $89 | $0 |
| Cash at End | $2.09M | $210K | $1.65M | $3.34M | $9.03M | $2.39M | $658K | $2.33M | $2.48M | $1.38M | $63K | $8K |